BUCCAL AND ORAL BIOAVAILABILITY OF NALOXONE AND NALTREXONE IN RATS

被引：39

作者：

HUSSAIN, MA ^{[1
]}

AUNGST, BJ ^{[1
]}

KEARNEY, A ^{[1
]}

SHEFTER, E ^{[1
]}

机构：

[1] DUPONT CO,DEPT MED PROD,EXPTL STN,BLDG 400,WILMINGTON,DE 19898

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1987年 / 36卷 / 2-3期

关键词：

D O I：

10.1016/0378-5173(87)90147-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：127 / 130

页数：4

共 14 条

[1] NALOXONE DECREASES FOOD-INTAKE IN OBESE HUMANS [J].

ATKINSON, RL .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (01) :196-198

[2]

BELL MDD, 1985, LANCET, V1, P71

[3] THE SYSTEMIC BIOAVAILABILITY OF BUPRENORPHINE BY VARIOUS ROUTES OF ADMINISTRATION [J].

BREWSTER, D ;

HUMPHREY, MJ ;

MCLEAVY, MA .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (08) :500-506

[4] ELECTROCHEMICAL CHROMATOGRAPHIC DETERMINATIONS OF MORPHINE ANTAGONISTS IN BIOLOGICAL-FLUIDS, WITH APPLICATIONS [J].

DERENDORF, H ;

ELDIN, A ;

ELKOUSSI, A ;

GARRETT, ER .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (05) :621-624

[5]

FISHMAN J, 1973, J PHARMACOL EXP THER, V187, P575

[6] PHARMACOKINETICS OF MORPHINE AND ITS SURROGATES .5. NALTREXONE AND NALTREXONE CONJUGATE PHARMACOKINETICS IN THE DOG AS A FUNCTION OF DOSE [J].

GARRETT, ER ;

ELKOUSSI, AEA .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (01) :50-56

[7] BUCCAL AND ORAL BIOAVAILABILITY OF NALBUPHINE IN RATS [J].

HUSSAIN, MA ;

AUNGST, BJ ;

SHEFTER, E .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (02) :218-219

[8]

KOGAN MJ, 1977, RES COMMUN CHEM PATH, V18, P29

[9]

MEYER MC, 1984, J CLIN PSYCHIAT, V45, P15

[10]

REISBERG B, 1983, NEW ENGL J MED, V308, P721

← 1 2 →